# NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center

> **NIH NIH UG1** · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2024 · $200,000

## Abstract

Project Summary/Abstract
The goal of the National Clinical Trials Network (NCTN) Lead Academic Participating Site at UPMC Hillman
Cancer Center, is to increase our level of participation in conceptualization, development, activation,
performance, and reporting of the late-phase clinical trials of the NRG Oncology, ECOG-ACRIN, and
Alliance for Clinical Trials in Oncology Network Groups. This will be accomplished by enhancing the quality
of our scientific and administrative leadership; increasing accruals to NCTN trials, with special efforts
directed at minority, rural and other special populations; improving our processes for rapid activation of new
trials, with special efforts directed at trials for rare cancers and genotypically-defined subpopulations; and
mentoring junior investigators in how to conduct phase 2 and phase 3 NCTN trials, and in the administrative,
scientific, and interpersonal skills needed for advancing into positions of leadership within the NCTN and
National Cancer Institute.

## Key facts

- **NIH application ID:** 11001262
- **Project number:** 3UG1CA233184-05S1
- **Recipient organization:** UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- **Principal Investigator:** ADAM M BRUFSKY
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $200,000
- **Award type:** 3
- **Project period:** 2019-05-01 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11001262

## Citation

> US National Institutes of Health, RePORTER application 11001262, NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center (3UG1CA233184-05S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11001262. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*